Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Cancer (Unresectable)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06592664
What this trial is testing

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Who this might be right for
Pancreas CancerPancreatic CarcinomaPancreas Adenocarcinoma+5 more
Lisata Therapeutics, Inc.
Testing effectiveness (Phase 2)UnknownNCT05346146
What this trial is testing

A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.

Who this might be right for
Unresectable Locally Advanced Pancreatic Cancer
RenJi Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT00031837
What this trial is testing

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerThromboembolism
Gary Morrow 400
Testing effectiveness (Phase 2)Study completedNCT01972919
What this trial is testing

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

Who this might be right for
Unresectable Pancreatic Cancer
Medical College of Wisconsin 23
Testing effectiveness (Phase 2)Ended earlyNCT00609765
What this trial is testing

Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 1
Not applicableStudy completedNCT05078775
What this trial is testing

Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma
Faeth Therapeutics 39
Early research (Phase 1)UnknownNCT00639925
What this trial is testing

Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fukushima Medical University 5
Testing effectiveness (Phase 2)Study completedNCT02132468
What this trial is testing

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

Who this might be right for
Neuroendocrine Tumors
Mateon Therapeutics 18
Testing effectiveness (Phase 2)Study completedNCT00113360
What this trial is testing

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine CarcinomaIslet Cell Carcinoma
M.D. Anderson Cancer Center 67
Testing effectiveness (Phase 2)Study completedNCT00003923
What this trial is testing

Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more
Memorial Sloan Kettering Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT05031494
What this trial is testing

Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers

Who this might be right for
MelanomaPancreatic Ductal Adenocarcinoma
Eucure (Beijing) Biopharma Co., Ltd 40
Testing effectiveness (Phase 2)Study completedNCT01304160
What this trial is testing

Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerUnresectable Pancreatic Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 10
Early research (Phase 1)Study completedNCT01294358
What this trial is testing

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Who this might be right for
Histologically or Cytologically Confirmed Pancreatic CaUnresectable or Borderline Resectable Pancreatic Ca
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT00655785
What this trial is testing

Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)

Who this might be right for
Pancreatic Cancer
Fukushima Medical University 17
Testing effectiveness (Phase 2)Study completedNCT02230176
What this trial is testing

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II

Who this might be right for
Pancreatic Neuroendocrine Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 84
Early research (Phase 1)Study completedNCT00622622
What this trial is testing

Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wakayama Medical University 21
Large-scale testing (Phase 3)Looking for participantsNCT07235930
What this trial is testing

Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer

Who this might be right for
Non-Resectable Pancreas Carcinoma
Zhejiang Cancer Hospital 292
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT01410968
What this trial is testing

A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Cancer
Carolyn Britten 12
Not applicableNo Longer AvailableNCT07399015
What this trial is testing

Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Unresectable Pancreatic Ductal AdenocarcinomaMetastatic PDAC
Endevica Bio
Next Page